| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.024 | 0.8 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |